Efficacy of Extracorporeal Shockwave Therapy on Ultrasonographic Changes in de Quervain Tenosynovitis
De Quervain Disease
About this trial
This is an interventional treatment trial for De Quervain Disease focused on measuring Extracorporeal Shockwave therapy :ESWT, Ultrasonography US, HandGrip Strenght, De Quervain Tenosynovitis
Eligibility Criteria
Inclusion Criteria: Age from 18 to 65 years Both genders (males and females). Normal BMI ranges between 18.5:24.9 kg/m2. Patients will be referred from an orthopedist with diagnosis of DQT. Chronic pain more than 2 months. No history of undergoing physiotherapy modalities or corticosterone injection therapies for any reasons during the past month. De Quervain tenosynovitis patients will be diagnosed based on the standard criteria, including pain and tenderness in the lateral wrist and a positive result for the Finkelstein test. Exclusion Criteria: History of undergoing physiotherapy modalities or corticosterone injection therapies for any reason during the past month. Subjects with other neurological disorders rheumatologic diseases causing wrist pain. Pregnancy. History of fracture or surgery on the hand. Severe trauma, and coagulation disorders.
Sites / Locations
- Mostafa Gomaa Mahmoud
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
The experimental Group A
The control Group B
Extracorporeal Shockwave therapy (four sessions one session per week) +Traditional physical therapy program (Instruction to wear Thumb Spica splint, Ultrasound therapy, stretching exercise & strengthening exercise) (two sessions per week for 4 weeks).
Traditional physical therapy program (Instruction to wear Thumb Spica splint, Ultrasound therapy, stretching exercise & strengthening exercise) (two sessions per week for 4 weeks).